Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Aerovate Therapeutics Inc (AVTE)

  • Event
  • May 16, 2022, 00:00 UTC
  • 21
  • 1 comments

(76% Positive) AEROVATE THERAPEUTICS, INC. (AVTE) Reports 75% Loss Reduction for 2022-03-31

Comment Full text

Centessa Pharmaceuticals plc (CNTA)

  • Event
  • May 16, 2022, 00:00 UTC
  • 21
  • 1 comments

(75% Positive) CENTESSA PHARMACEUTICALS PLC (CNTA) Reports 100% Loss Reduction for 2022-03-31

Comment Full text

Passage Bio Inc (PASG)

  • Event
  • May 16, 2022, 00:00 UTC
  • 20
  • 1 comments

(52% Neutral) PASSAGE BIO, INC. (PASG) Reports Net Loss for 2022-03-31

Comment Full text

Akebia Therapeutics Inc (AKBA)

  • Event
  • May 13, 2022, 21:27 UTC
  • 10
  • 1 comments

(70% Positive) AKEBIA THERAPEUTICS, INC. (AKBA) Announces Regulatory Update

Comment Full text

Kezar Life Sciences Inc (KZR)

  • Event
  • May 13, 2022, 20:56 UTC
  • 10
  • 1 comments

(99% Neutral) Kezar Life Sciences, Inc. (KZR) Announces New Board Appointment

Comment Full text

RedHill Biopharma (RDHL)

  • Event
  • May 13, 2022, 13:00 UTC
  • 9
  • 1 comments

(99% Neutral) RedHill Biopharma (RDHL) Announces 2022 Annual General Meeting

Comment Full text

Rubius Therapeutics (company was delisted NASDAQ) (RUBY)

  • Event
  • May 13, 2022, 12:30 UTC
  • 10
  • 1 comments

(99% Neutral) RUBIUS THERAPEUTICS, INC. (RUBY) Announces Regulatory Update

Comment Full text

Leap Therapeutics Inc (LPTX)

  • Event
  • May 13, 2022, 11:10 UTC
  • 10
  • 1 comments

(10% Negative) Leap Therapeutics, Inc. (LPTX) Reports Q2 2022 Financial Results

Comment Full text

Humacyte Inc (HUMA)

  • Event
  • May 13, 2022, 11:03 UTC
  • 10
  • 1 comments

(30% Negative) Humacyte, Inc. (HUMA) Reports Q2 2022 Financial Results

Comment Full text

Leap Therapeutics Inc (LPTX)

  • Event
  • May 13, 2022, 00:00 UTC
  • 18
  • 1 comments

(76% Positive) LEAP THERAPEUTICS, INC. (LPTX) Reports Net Loss for 2022-03-31

Comment Full text
  • Previous
  • 221
  • 222
  • 223
  • 224
  • 225
  • Next

Search

News categories

  • Technical Exchange News(10896)
  • Event(2296)
  • SEC News(190041)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124780)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin